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Patients residing in remote locations may be more likely to
initiate peritoneal dialysis when starting renal replacement
therapy to avoid relocation. These patients may have
reduced access to medical care, however. To examine the
hypothesis that patients residing some distance from their
nephrologists would be more likely to select peritoneal
dialysis but have an increased risk of mortality, we used
prospectively collected data in a random sample of 26 775
patients initiating dialysis in Canada between 1990 and 2000.
The distance between the patient’s residence at dialysis
inception and the practice location of their nephrologists was
calculated. We used Cox proportional hazard models to
determine the adjusted relation between this distance and
clinical outcomes over a mean follow-up period of 2.5 years
up to 14 years. Remote-dwelling patients were more likely
than urban dwellers to commence peritoneal dialysis in
distances ranging from 50 to greater than 300 km than those
residing within 50 km. The adjusted rates of death and the
adjusted hazard ratio among patients initiating peritoneal
dialysis was significantly higher in those living further from
the nephrologists than those living within 50 km. Further
study into the quality of care delivered to remote-dwelling
patients on peritoneal dialysis is needed.
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Hemodialysis and peritoneal dialysis (PD) are the two major
dialytic modalities used to treat patients with kidney failure.
Both modalities require ongoing supervision by a nephrologist
to adjust the dialysis prescription and manage complications,
and there is little evidence that either is clinically superior.1,2
However, since PD patients typically perform the treatment
themselves in their own homes, they tend to have more
autonomy than those treated with hemodialysis, who typically
must travel to a health-care facility at least three times weekly
to receive their dialysis treatment. Despite this potential
advantage, the proportion of patients initiating renal replace-
ment therapy on PD has declined steadily in recent years in
North America and elsewhere.3,4
Canada is a large country and Canadian nephrologists
tend to be concentrated in major urban centers, suggesting
that selection of a dialytic modality may be influenced by
geographical considerations. Specifically, patients living
further from major centers may be more inclined to select
PD to avoid relocation to an area served by a hemodialysis
unit. On the other hand, remote residence location might act
as a geographical barrier to proper care once established on
PD. Thus, it is plausible that patients who live further away
from nephrology services may be more likely to initiate renal
replacement on PD—allowing them to avoid relocation, but
at the expense of adverse clinical outcomes. Despite its
potential implications for health policy and clinical practice,
no studies have examined this issue.
We used prospectively collected data from patients
initiating dialysis in Canada between 1990 and 2000 to
examine this issue. We hypothesized that patients residing
further away from their attending nephrologist would be
more likely to initiate renal replacement on PD, but would
have an increased risk of technique failure and mortality after
commencing dialysis.
RESULTS
Patient characteristics
Among the 73% sample of 26 808 individuals who com-
menced renal replacement therapy during the study period,
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distance between their residence and the practice location of
their nephrologist could be determined for 26 775 (499%).
Of these, 7376 of 26 098 (28%) adult patients initiated
treatment on PD. Most such patients (70%) lived within
50 km of their attending nephrologist at dialysis inception.
However, 593 (8%) lived 150.1–300 km away, and 456 (6%)
lived 4300 km from their attending nephrologist. Patients
who lived further away were more likely to be Aboriginal,
younger, and to smoke compared to those who lived closer to
their attending nephrologist (Table 1). Diabetic nephropathy
as the cause of end-stage renal disease occurred more
frequently in patients residing further from their attending
nephrologist. Chronic heart failure occurred less frequently in
patients residing further away, while chronic lung disease and
malignancy occurred more frequently in these remote dwellers.
Other documented comorbidities were similar in patients
residing close to and far from their attending nephrologist.
PD use
Remote-dwelling patients were significantly more likely than
urban dwellers to commence renal replacement therapy on
PD. Multivariate logistic regression showed that the odds
ratios of initiating dialysis on PD in people living 50.1–150,
150.1–300, and 4300 km from the closest nephrologist were
1.26 (95% confidence interval (CI) 1.16, 1.37), 1.64 (95% CI
1.46, 1.83), and 1.83 (95% CI 1.60, 2.08), respectively,
compared with those residing within 50 km (P-value for
trend o0.0001; Table 2). The increased likelihood of
initiating renal replacement on PD with greater distance
from the nephrologists was observed for both automated and
continuous ambulatory forms of PD. However, among those
commencing dialysis treatment on PD, the proportion using
automated PD was substantially higher in those living
o50 km from their attending nephrologist, compared to
those living 4300 km away (40 vs 12%, Po0.0001).
The proportion for whom PD was the initial modality
significantly decreased during the study period for patients who
lived o50, 50–150, and 150.1–300 km from their nephrologist
(all Po0.0001), but not for those residing 4300 km away
(P¼ 0.54; P-value for interaction 0.008; Figure 1). Tests for
interaction between age, race, diabetic status or socioeconomic
status, and residence location were all nonsignificant, suggesting
that the association between residence location and initial use of
PD was not influenced by these characteristics.
Switches from hemodialysis to PD
In addition to initiating dialysis more frequently on PD,
remote-dwelling patients were also more likely to switch
from hemodialysis to PD than those living closer (Table 3).
An adjusted Cox regression model showed that the hazard
ratios of switching permanently onto PD among hemodia-
lysis patients living 50.1–150, 150.1–300, and 4300 km from
the closest nephrologist were 2.35 (95% CI 2.10, 2.63), 2.90
(95% CI 2.51, 3.35), and 4.42 (95% CI 3.82, 5.11),
respectively, compared with those residing within 50 km
(P-value for trend o0.0001).
PD technique failure
Among subjects living 4300 km from their nephrologist and
initiating renal replacement on PD, the adjusted rate of
technique failure was 12 per 100 patient-years (95% CI 9–16),
and was significantly lower than that in patients living within
50 km of their attending nephrologist (19, 95% CI 16–22).
Similar results were observed in Cox regression analysis,
which showed that the adjusted likelihood of technique
failure in people living 50.1–150, 150.1–300, and 4300 km
from the closest nephrologist was 0.86 (95% CI 0.75, 0.97),
0.78 (95% CI 0.65, 0.94), and 0.63 (95% CI 0.50, 0.79),
respectively, compared with those residing within 50 km (P-
value for trend o0.0001; Table 4). Stratification on dialytic
submodality suggested that the reduced risk of technique
failure in remote dwellers was similar in those using
automated PD and continuous ambulatory PD (P-value for
interaction 0.14).
Mortality
During the median follow-up period of 2.5 years (inter-
quartile range 1.0–4.3 years), 4278 (58%) of patients died.
Mortality among patients initiating PD was significantly
higher in those living further from their nephrologist.
Adjusted rates (95% CI) of death per 100 person-years were
13.4 (11.9, 15.0), 14.9 (13.0, 17.0), 14.3 (12.2, 16.7), and 15.0
(12.7, 17.7) in those living within 50 km, 50.1–150, 150.1–300,
and 4300 km from the closest nephrologist, respectively
(P-value for trend o0.0001). Compared to those living
within 50 km of their nephrologist, the adjusted hazard ratio
of death in people living 50.1–150, 150.1–300, and 4300 km
from the closest nephrologist was 1.17 (95% CI 1.07, 1.27),
1.07 (95% CI 0.95, 1.21), and 1.15 (95% CI 1.00, 1.32),
respectively, as compared with those living within 50 km
(P-value for trend 0.03; Table 5). Adjustment for physician
supply did not influence our results, suggesting that reduced
access to local primary care physicians or non-nephrologist
specialists was not responsible for the increased risk of death
among remote dwellers.
When expressed as life expectancy from dialysis initiation,
these differences between distance categories were modest.
For example, predicted median survival among male
diabetics greater than 65 years of age was 2.9 years (95%
CI 2.6, 3.2) for those residing p50 km from their
nephrologist, and 2.6 years (2.2, 3) for those living
4300 km from their nephrologist. Corresponding predicted
median survival for female non-diabetics less than 65 years of
age were 7.1 years (6.1, 8.3) and 6.4 years (5.3, 7.7) in the
closest and furthest distance categories, respectively. Differ-
ences between those living close to and far from their
nephrologist were similar in other categories defined by age,
sex, and diabetic status (data not shown).
DISCUSSION
Remote-dwelling Canadians with kidney failure were sig-
nificantly more likely to initiate renal replacement on PD,
and also to switch onto PD if their initial dialytic modality
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was hemodialysis. In addition, the secular decrease in the
proportion of incident patients initiating dialysis on PD was
not present among remote dwellers. The expected increase in
the risk of technique failure among remote dwellers was not
observed. Instead, the likelihood of technique failure among
those treated with PD decreased with greater distance from
the attending nephrologist, but a small independent increase
in the risk of death was noted—with remote dwellers dying
approximately 3–5 months sooner than those living within
50 km of their nephrologist.
Why was the risk of death higher among remote dwellers?
Our data and clinical intuition suggest that such patients are
often healthier than urban dwellers. While it is possible that
Table 1 | Demographic and clinical characteristics, by distance from the attending nephrologist among patients initiating
dialysis on PD
p50 km 50.1–150 km 150.1–300 km 4300 km P-value
N 5145 (70) 1182 (16) 593 (8) 456 (6)
Age (years)* 62 (48, 71) 62 (47, 72) 61 (46, 71) 58 (45, 67) 0.0001
Male 2950 (57) 663 (56) 338 (57) 242 (53) 0.33
Race
White 3649 (71) 1020 (86) 505 (85) 328 (72) o0.0001
Aboriginal 61 (1) 36 (3) 41 (7) 91 (20) o0.0001
Other 1156 (22) 31 (3) 19 (3) 10 (2) o0.0001
Unknown 279 (5) 95 (8) 28 (5) 27 (6) 0.004
Cause of kidney failure
Diabetic nephropathy 1692 (33) 383 (32) 196 (33) 187 (41) 0.005
Glomerulonephritis 1001 (19) 209 (18) 111 (19) 63 (14) 0.02
Hypertensive/ischemic 1000 (19) 210 (18) 99 (17) 52 (11) 0.0002
Polycystic kidney disease 251 (5) 76 (6) 31 (5) 31 (7) 0.08
Other 1201 (23) 304 (26) 156 (26) 123 (27) 0.08
Comorbidity
Diabetes mellitus 255 (5) 70 (6) 44 (7) 13 (3) 0.005
Coronary disease 1528 (30) 319 (27) 162 (27) 123 (27) 0.15
Hypertension 4006 (78) 892 (75) 457 (77) 351 (77) 0.36
Chronic heart failure 1336 (26) 257 (22) 123 (21) 82 (18) o0.0001
Stroke or TIA 450 (9) 108 (9) 64 (11) 31 (7) 0.15
Chronic lung disease 316 (6) 99 (8) 39 (7) 42 (9) 0.006
Peripheral vascular dis. 744 (14) 159 (13) 89 (15) 56 (12) 0.47
Malignancy 305 (6) 70 (6) 54 (9) 32 (7) 0.02
Current smoker 580 (11) 170 (14) 81 (14) 92 (20) o0.0001
Lowest quintile of SES 1194 (23) 251 (21) 144 (24) 113 (25) 0.32
Region of residence
Atlantic Canada 186 (4) 202 (17) 171 (29) 117 (26) o0.0001
Quebec 931 (18) 188 (16) 54 (9) 99 (22) o0.0001
Ontario 2873 (56) 484 (41) 126 (21) 89 (20) o0.0001
Manitoba 137 (3) 29 (2) 17 (3) 25 (5) 0.005
Saskatchewan 71 (1) 52 (4) 74 (12) 32 (7) o0.0001
Alberta 279 (5) 66 (6) 79 (13) 31 (7) o0.0001
British Columbia 668 (13) 161 (14) 72 (12) 63 (14) 0.8
Year of dialysis initiation
1990–1992 1313 (26) 287 (24) 158 (27) 117 (26) 0.72
1993–1994 1000 (19) 235 (20) 133 (22) 72 (16) 0.06
1995–1996 942 (18) 227 (19) 98 (17) 87 (19) 0.56
1997–1998 884 (17) 232 (20) 103 (17) 91 (20) 0.13
1999–2000 1006 (20) 201 (17) 101 (17) 89 (20) 0.13
PD, peritoneal dialysis; SES, socioeconomic status; TIA, transient ischemic attack.
Values are N (%), except for * which is median (interquartile range).
Distances refer to the distance by road between each patient’s residence location at the time of dialysis initiation and the practice location of his/her attending nephrologist.
Table 2 | Odds of initiating renal replacement on peritoneal
dialysis by distance from the attending nephrologist
Age-adjusted
OR (95% CI)
Fully adjusteda
OR (95% CI)
Linear (every 100 km) 1.07 (1.05, 1.1) 1.14 (1.12, 1.17)
p50 km 1.0 1.0
50.1–150 km 1.13 (1.05, 1.22) 1.26 (1.16, 1.37)
150.1–300 km 1.27 (1.14, 1.41) 1.64 (1.46, 1.83)
4300 km 1.33 (1.18, 1.50) 1.83 (1.60, 2.08)
Trend P-value o0.0001 o0.0001
CI, confidence interval; OR, odds ratio.
aAdjusted for age, sex, race, primary cause of kidney failure, comorbidities, smoking
status, socioeconomic status, geographic region of residence, and year of dialysis
initiation.
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baseline comorbidity was less thoroughly documented in
remote dwellers due to reduced access to nephrologists before
dialysis initiation, this would have tended to bias toward the
null (similar mortality in remote and urban dwellers).
Although remote dwellers might have reduced access to local
physicians (primary care and specialists), adjustment for an
accepted index of physician supply did not change our
findings.5
One potential explanation for our findings is that they
simply reflect reduced access to appropriate health care
among remote dwellers. Canadians residing outside major
centers have less access to specialized services such as cardiac
catheterization, preoperative clinics and maternal-fetal
screening.6–8 However, whether this reduced ability to utilize
health services leads to worse clinical outcomes is less clear.
Rural-dwelling Canadians have higher mortality following
trauma and certain types of cancer,9,10 but perhaps not after
pneumonia, myocardial infarction, or acute heart failure,11–13
and even less is known about comparative health outcomes in
rural dwellers with chronic conditions such as kidney failure.
Thus, this explanation is plausible but unproven.6–13
Clinical experience suggests that some patients fare better
on hemodialysis than PD, and published guidelines stress the
importance of patient selection and close monitoring after
initiation of PD. It seems likely that remote dwellers may
have less frequent or less comprehensive contact with
nephrologists than those living in major centers. This might
lead to deficiencies in care, including the failure to
recommend a switch to hemodialysis when medically
indicated. If these practices truly improve clinical outcomes
in PD patients, a second possibility for our findings is that
some remote-dwelling patients with kidney failure exchange
the greater autonomy associated with PD (allowing them to
avoid relocation) for a slight reduction in life expectancy
(potentially due to failure to switch to hemodialysis when PD
is no longer medically appropriate and/or to suboptimal
50
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Figure 1 | Proportion of incident dialysis patients with peritoneal
dialysis as the initial modality over time, stratified by distance
from the attending nephrologist. The figure shows that the
proportion of dialysis patients initiating renal replacement on
peritoneal dialysis over time (1990–2000) declined for all categories
of residence location at the same rate except those living 4300 km
from their nephrologist (P-value for interaction 0.008).
Table 3 | Relative likelihood of switching permanently from
hemodialysis to peritoneal dialysis by distance from the
attending nephrologist
Age-adjusted
HR (95% CI)
Fully adjusteda
HR (95% CI)
Linear (every 100 km) 1.32 (1.29, 1.35) 1.29 (1.26, 1.33)
p50 km 1.0 1.0
50.1–150 km 2.38 (2.13, 2.65) 2.35 (2.10, 2.63)
150.1–300 km 3.22 (2.81, 3.69) 2.90 (2.51, 3.35)
4300 km 4.63 (4.04, 5.31) 4.42 (3.82, 5.11)
Trend P-value o0.0001 o0.0001
CI, confidence interval; HR, hazard ratio.
aAdjusted for age, sex, race, primary cause of kidney failure, comorbidities, smoking
status, socioeconomic status, geographic region of residence, and year of dialysis
initiation.
Table 4 | Relative hazard of technique failure by distance from the attending nephrologist
All patients fully adjusteda
HR (95% CI)
APD patients fully adjusteda
HR (95% CI)
CAPD patients fully adjusteda
HR (95% CI)
Linear (every 100 km) 0.91 (0.87, 0.95) 0.88 (0.78, 0.98) 0.92 (0.88, 0.97)
p50 km 1.0 1.0 1.0
50.1–150 km 0.86 (0.75, 0.97) 1.05 (0.84, 1.32) 0.80 (0.69, 0.94)
150.1–300 km 0.78 (0.65, 0.94) 0.86 (0.57, 1.29) 0.77 (0.62, 0.95)
4300 km 0.63 (0.50, 0.79) 0.47 (0.24, 0.92) 0.68 (0.53, 0.86)
Trend P-value o0.0001 0.04 0.0004
APD, automated peritoneal dialysis; CAPD, continuous ambulatory peritoneal dialysis; CI, confidence interval; HR, hazard ratio.
aAdjusted for age, sex, race, primary cause of kidney failure, comorbidities, smoking status, socioeconomic status, geographic region of residence, and year of dialysis
initiation.
Table 5 | Relative hazard of mortality by distance from the
attending nephrologist in peritoneal dialysis patients
Age-adjusted
HR (95% CI)
Fully adjusteda
HR (95% CI)
Linear (every 100 km) 1.06 (1.03, 1.08) 1.02 (1.00, 1.05)
p50 km 1.0 1.0
50.1–150 km 1.26 (1.16, 1.37) 1.17 (1.07, 1.27)
150.1–300 km 1.23 (1.10, 1.38) 1.07 (0.95, 1.21)
4300 km 1.30 (1.14, 1.47) 1.15 (1.00, 1.32)
Trend P-value o0.0001 0.03
CI, confidence interval; HR, hazard ratio.
aAdjusted for age, sex, race, primary cause of kidney failure, comorbidities, smoking
status, socioeconomic status, geographic region of residence, and year of dialysis
initiation.
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dialysis care). Although this speculation is provocative, it is
important to recognize that the apparent link between higher
PD uptake, lower technique failure, and slightly higher
mortality among remote-dwelling patients may not be causal
and that our data do not permit us to determine the
explanation for the higher mortality in this population.
If confirmed by future studies, this hypothesis would
suggest that changes in health policy are required, since
physician reimbursement often does not encourage the
provision of good quality care to remote-dwelling patients.14
Alternatively, increased use of telemedicine may facilitate
closer follow-up of patients who live at a distance from their
nephrologist.15 Future work should compare markers of good
quality care in urban and remote-dwelling PD patients,
focusing on those which are amenable to intervention.
Studies comparing the factors that lead to technique failure
in remote-dwelling as compared with urban-dwelling pa-
tients would also be potentially useful.
Although minimizing mortality is often a valid objective
for the care of dialysis patients, it is important to recognize
that residence relocation (to permit initiation of hemodia-
lysis) is associated with adverse social and financial
consequences,16,17 especially for older patients. Therefore,
even if the slightly lower life expectancy among remote
dwellers is causally related to remote residence location, the
relatively small magnitude of this difference may be
reassuring to those patients who would prefer to remain in
their own homes (rather than relocate to an area which is
closer to their nephrologist).
Our study has several limitations. First, we relied on
registry data, the limitations of which are well known.
Second, we excluded participants without a valid residential
postal code, although these individuals accounted for o1%
of those initiating dialysis during the study period. Third, our
classification of residence location was based on data at the
time of dialysis inception. Since some participants may have
moved after commencing dialysis but before transplantation,
the resulting misclassification may have introduced bias.
Fourth, although previously validated, the methodology we
used to calculate distance necessitates some approximations.
We attempted to reduce the impact of this imprecision by
categorizing distance from care into relatively broad cate-
gories, reducing the risk of misclassification. Fifth, although
remote dwellers in the general population may have a slightly
higher risk of death than otherwise comparable urban
dwellers, the magnitude of the increased risk is small
(approximately 0.1 excess deaths per 100 person-years),18
which would not explain our findings. Finally, we did not
have information on compliance with therapy, specific
contraindications to PD, living conditions, or social support,
all of which might potentially have influenced the clinical
outcomes that we studied.
In conclusion, we found that remote-dwelling Canadians
with kidney failure were significantly more likely to initiate
renal replacement on PD, and also to switch onto PD if their
initial dialytic modality was hemodialysis. However, this
group also had a modestly increased risk of death after
dialysis initiation. Future work should carefully compare the
quality of care delivered to remote and urban PD patients.
MATERIALS AND METHODS
Study population and data sources
This study was approved by the Ethics Review Board at the
University of Alberta and was conducted on a random sample of
data from the Canadian Organ Replacement Registry,19 which
collects patient-specific data annually from all Canadian dialysis
centers. Using a two-step process, which ensured the privacy of
participants, we received a participant-level data set from Canadian
Organ Replacement Registry, which included a unique identifier and
the patient’s residential postal code at the time of dialysis initiation
for a random 75% sample of all patients initiating dialysis in Canada
between 1 January 1990 and 31 December 2000 (n¼ 26 808). Of
these, the residential postal code was valid for 26 755 individuals
(499%). We calculated the geographic coordinates for each
patient’s residence using the Canadian Postal Code conversion
file,20 and determined the practice location of their attending
nephrologist or group of nephrologists based on information
submitted to Canadian Organ Replacement Registry. Next, we
calculated the distance between the patient’s residence location and
the relevant nephrology practice for these 26 755 participants
(described below). After excluding children (ageo18 years,
n¼ 236), we returned the data to Canadian Organ Replacement
Registry, and performed analyses on a linked data set which
included clinical and demographic data, geographical location, and
distance from the attending nephrologist for approximately 73% of
all participants initiating dialysis in Canada during the study.
Estimation of physician supply and socioeconomic status
The Canadian census reports data in geographic units such as
Census Consolidated Subdivisions constitute municipalities or their
deemed equivalents. Since local physician supply and the socio-
economic attributes of areas in which people reside may influence
their access to health care,21 we assessed these characteristics for each
Census Consolidated Subdivisions. Data from the Southam Medical
Database were used to determine the population to physician ratio
(calculated separately for primary care and specialist physicians) in
each Census Consolidated Subdivisions during the year that each
patient initiated dialysis.5 We estimated socioeconomic status using
the Neighbourhood Income Per Person Equivalent, a household
size-adjusted measure of household income, based on 1996
Canadian census summary data.20
Estimation of distance
We determined the geographic coordinates for each six digit postal
code using the Statistics Canada Postal Code Conversion File and
Canadian Postal*Data software (MelissaData Corporation, Rancho,
Santa Margarita, CA, USA). We entered these coordinates into
ArcGIS 9.1 software (ESRI Corporation, Redlands, CA, USA) to
determine the shortest distance by road (in km) between the
residence of a dialysis patient at the time of dialysis initiation and
the practice location using methods described previously.22–24
Analyses
Outcomes of interest included PD use as the initial form of renal
replacement therapy, PD technique failure and all-cause mortality
after initiation of PD. We defined PD technique failure as a switch
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from PD to hemodialysis that was sustained for at least 90 days. We
attempted to classify technique failure as peritonitis related or
peritonitis unrelated, but found that information on the cause of
technique failure was missing in a large number of subjects. Subjects
with more than one episode of technique failure were counted only
once, with the date of their earliest technique failure used. We also
examined switches from hemodialysis onto PD, defined as at least 90
days of PD treatment in a patient previously maintained on
hemodialysis. In all analyses, we censored follow-up at loss to
follow-up, renal transplantation, or end of study (31 December 2004).
We investigated the effects of residence location (distance from
the patient’s residence to their nephrologist) on the clinical
outcomes after arbitrarily categorizing distance from the nephrol-
ogist into the following a priori categories: 0–50, 50.1–150,
150.1–300, and 4300 km. We assigned participants living in remote
communities for which no consistent access by road was available to
the 4300 km category. We made comparisons between participants
residing in different distance categories using the w2-test for
frequency data and the Kruskal–Wallis test for continuous data.
Statistical significance was set at Pp0.05.
We report a fully adjusted Cox proportional hazards model. In
addition to residence location and neighborhood socioeconomic
status, other factors considered included age; sex; race (white,
Aboriginal, or other); cause of kidney failure (diabetic nephropathy,
glomerulonephritis, hypertensive/ischemic renal disease, polycystic
kidney disease, and other renal disease); year of dialysis initiation;
comorbid conditions including diabetes mellitus, coronary disease,
hypertension, current heart failure, stroke or transient ischemic
attack, chronic lung disease, peripheral vascular disease, malignancy,
other serious illnesses; smoking status; and geographic region
(Atlantic Canada, Quebec, Ontario, Manitoba, Saskatchewan,
Alberta, and British Columbia). To determine whether the effects
of residence location differed by age, socioeconomic status, or
diabetic status, we explored their two-way interactions on the
likelihood of PD use, technique failure, and death. We determined
that the proportional hazard assumption was satisfied by examining
plots of the log-negative-log of the within group survivorship
probabilities vs log-time. We calculated predicted life expectancy
using fully adjusted log-logistic models with covariate values fixed at
the most frequent level.
We dealt with missing data by assuming that the characteristic
was absent (4% had missing data on one or more comorbidities).
Results did not differ when analyses were repeated after deleting all
participants with missing data, so we have reported results using the
former method. To deal with other methodological uncertainties, we
conducted the following sensitivity analyses. To determine if the
relation between clinical outcomes and residence location was
influenced by type of PD, we repeated the primary analysis
considering only patients treated with automated PD or only
continuous ambulatory PD. We also categorized distance into seven
categories (0–100, 100.1–200, 200.1–300, 300.1–400, 400.1–500,
500.1–600, and 4600 km) as well as the four in the primary analysis.
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